UNSPSC 51202602: Anisperimus

This classification denotes an immunosuppressant with the molecular formula C18H39N7O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0514P112G. The term ANISPERIMUS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, list 44). As of Q4 2014, ANISPERIMUS remains US FDA's Preferred Term for this commodity. Anisperimus bears US NLM identifiers UMLS ID C2698118 and NCI Concept Code C77593.

Most nations, for tariff and trade purposes, schedule Anisperimus under HS 29252900 and SITC 51482 (for the most current information on WCO designations on anisperimus and salts thereof, please see Committee proceedings HSC/53, NC2004B1b Ann. O/6, 2014). SMILES: C[C@H](CCNCCCCNC(=O)OCC(=O)NCCCCCCNC(=N)N)N.

UNSPSC 51202602 Anisperimus is a Commodity code under which state and local governments procure naloxone, safe drug deactivation systems, generic pharmaceuticals, over-the-counter products, and medical and first aid supplies for public health, emergency response, and pharmacy benefit programs. Recent solicitations show health departments, county health systems, fire departments, and state pharmacy agencies buying these products in bulk for distribution to community health facilities, emergency responders, and retail pharmacy networks. The work spans product procurement with volume commitments, logistics coordination, compliance with drug supply chain security and manufacturing standards, and ongoing inventory management across multiple delivery points and participating institutions.

Issuing bodies include county health departments, municipal fire departments, state health and human services commissions, and cooperative purchasing alliances representing multiple state and local members. Recent activity appears concentrated in Florida and Minnesota, with cross-state participation through cooperative arrangements. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies including respiratory equipment, cardiac monitoring electrodes, and medical consumables for the Tampa Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered Small Local Business Enterprise opportunity with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed through authorized wholesalers across participating state and local government facilities in Minnesota and Oregon, with contract effectiveness July 1, 2026.